I
Immatics NV D
D
IMTX
6.21000
USD
-0.12
(-1.82%)
مغلق
حجم التداول
32,553
الربح لكل سهم
0
العائد الربحي
-
P/E
-9
حجم السوق
754,884,538
الأخبار المقالات
العنوان: Immatics NV
القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.